abstract |
The present invention relates to a novel compound having GPR119 agonistic activity, a process for its production, and a pharmaceutical composition containing the same as an active ingredient. The present invention relates to a novel compound having GPR119 agonistic activity, And has a therapeutic and / or preventive effect on metabolic diseases such as diabetes. |